HealthWarehouse.com(OTC) HEWA

HealthWarehouse.com, Inc. operates as a digital and direct-mail pharmaceutical service, providing a wide range of pharmaceutical products. The company focuses on delivering both generic and brand-name prescription drugs, as well as over-the-counter remedies, directly to consumers across the United States.

Products and Services

• Online platform for purchasing prescription and over-the-counter medications
• Specialized medications for pets
• Direct-to-consumer sales model targeting all 50 states

Growth Outlook

• Revenue of $6.13 million in Q2 2026, showing consistent sales
• Gross profit margin improved to 54.6% in Q2 2026
• Focus on expanding product offerings to enhance market reach

Financial Highlights

• Trailing twelve months (TTM) revenue of $25.5 million
• Net income of -$414,000 in Q2 2026, indicating ongoing operational challenges
• Current ratio of 0.44, reflecting liquidity concerns

HealthWarehouse.com, Inc. is positioned within the healthcare sector, specifically in the medical-pharmaceutical industry. The company has established a digital platform that allows consumers to access a variety of pharmaceutical products conveniently. With a focus on direct sales, HealthWarehouse.com aims to cater to the growing demand for online pharmaceutical services. The growth outlook appears promising, with recent quarterly revenue figures indicating a stable sales trajectory. The improvement in gross profit margin suggests effective cost management strategies are being implemented. However, the company faces challenges, as evidenced by the negative net income reported in the latest quarter. Financially, the trailing twelve months revenue reflects a solid performance, yet the current ratio indicates potential liquidity issues that may need addressing. Investors may find the company's strategic focus on expanding its product offerings and enhancing its online presence to be key factors in its future growth potential.